Pear Therapeutics Funding & Investors
Boston, MA
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective services for payors.
peartherapeutics.comTotal Amount Raised: $409,000,000
Pear Therapeutics Funding Rounds
IPO
Unknown
Post Ipo Equity
$125,000,000
Post Ipo Equity Investors
Shanda5am VenturesForth ManagementSoftBank Vision FundBlue Water Life Science FundQUAD Investment ManagementNeuberger BermanTemasek Holdings (Private)Palantir CapitalPilot House VenturesJazz Venture PartnersArboretum VenturesdRx CapitalSarissa Capital ManagementThe Eleven FundPritzker Vlock Family OfficeTrustbridge PartnersSeries D
$20,000,000
Series D
$80,000,000
Series D Investors
SoftBank Vision FundEDBITemasek Holdings (Private)QUAD Investment Management5am VenturesArboretum VenturesJazz Venture PartnersForth ManagementCrimsonox CapitalNovartisShandaPilot House VenturesSarissa Capital ManagementDebt Financing
$50,000,000
Debt Financing Investors
Perceptive AdvisorsSeries C
$64,000,000
Series C Investors
Temasek Holdings (Private)EDBIArboretum VenturesJazz Venture PartnersNovartisBlue Water Life Science Fund5am VenturesBridge Builders CollaborativeTrustbridge PartnersSeries B
$50,000,000
Series B Investors
Temasek Holdings (Private)Bridge Builders CollaborativeNovartis5am VenturesEDBIJazz Venture PartnersArboretum VenturesdRx CapitalSeries A
$20,000,000
Series A Investors
5am VenturesArboretum VenturesJazz Venture PartnersBridge Builders CollaborativeNovartis
Funding info provided by Diffbot.